First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer

First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer have?

First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer has 70 citations in the OpenAlex counts ScholarIQ stores.

When was First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer published?

First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer has 2008 year in the ScholarIQ index.

What is the open-access status of First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer?

First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer has closed oa status in the ScholarIQ index.

What is the DOI of First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer?

The DOI for First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer is on the source record.

What is the PMID of First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer?

The PMID for First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer is on the source record.

What is the OpenAlex record for First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer?

The OpenAlex for First- or Second-line Therapy with Gefitinib Produces Equal Survival in Non–Small Cell Lung Cancer is on the source record.